Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C FIELDS

Showing results (531-540 of 623) with videos related to

Pageof 63
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2024
HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal AdenocarcinomaNaomi Yamamoto, Stephanie Dobersch, Ian Loveless, et al.
Neuroendocrinology|February 11, 2020
Long-Term Outcomes after Spleen-Preserving Distal Pancreatectomy for Pancreatic Neuroendocrine Tumors: Results from the US Neuroendocrine Study GroupKota Sahara, Diamantis I Tsilimigras, Amika Moro, et al.
Annals of Surgical Oncology|March 29, 2020
Impact of Insurance Status on Survival in Gastroenteropancreatic Neuroendocrine TumorsPaula Marincola Smith, Jordan Baechle, Marcus C Tan, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 20, 2019
Predictive Value of Chromogranin A and a Pre-Operative Risk Score to Predict Recurrence After Resection of Pancreatic Neuroendocrine TumorsAlexander V Fisher, Alexandra G Lopez-Aguiar, Victoria R Rendell, et al.
The American Surgeon|November 11, 2021
Resection Status Does Not Impact Recurrence in Well-Differentiated Liposarcoma of the ExtremityChelsea R Olson, Lorena P Suarez-Kelly, Cecilia G Ethun, et al.
Annals of Surgical Oncology|August 7, 2016
Changing Odds of Survival Over Time among Patients Undergoing Surgical Resection of Gallbladder CarcinomaStefan Buettner, Georgios Antonios Margonis, Yuhree Kim, et al.
Annals of Surgical Oncology|November 11, 2015
Preoperative Helicobacter pylori Infection is Associated with Increased Survival After Resection of Gastric AdenocarcinomaLauren M Postlewait, Malcolm H Squires, David A Kooby, et al.
Journal of Surgical Oncology|December 6, 2017
Oncologic effects of preoperative biliary drainage in resectable hilar cholangiocarcinoma: Percutaneous biliary drainage has no adverse effects on survivalXu-Feng Zhang, Eliza W Beal, Katiuscha Merath, et al.
JAMA Surgery|October 27, 2016
Association of Optimal Time Interval to Re-resection for Incidental Gallbladder Cancer With Overall Survival: A Multi-Institution Analysis From the US Extrahepatic Biliary Malignancy ConsortiumCecilia G Ethun, Lauren M Postlewait, Nina Le, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 30, 2016
Elevated NLR in gallbladder cancer and cholangiocarcinoma - making bad cancers even worse: results from the US Extrahepatic Biliary Malignancy ConsortiumEliza W Beal, Lai Wei, Cecilia G Ethun, et al.
Pageof 63

Showing results (531-540 of 623) with videos related to

Sort By:
Pageof 63
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2024
HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal AdenocarcinomaNaomi Yamamoto, Stephanie Dobersch, Ian Loveless, et al.
Neuroendocrinology|February 11, 2020
Long-Term Outcomes after Spleen-Preserving Distal Pancreatectomy for Pancreatic Neuroendocrine Tumors: Results from the US Neuroendocrine Study GroupKota Sahara, Diamantis I Tsilimigras, Amika Moro, et al.
Annals of Surgical Oncology|March 29, 2020
Impact of Insurance Status on Survival in Gastroenteropancreatic Neuroendocrine TumorsPaula Marincola Smith, Jordan Baechle, Marcus C Tan, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 20, 2019
Predictive Value of Chromogranin A and a Pre-Operative Risk Score to Predict Recurrence After Resection of Pancreatic Neuroendocrine TumorsAlexander V Fisher, Alexandra G Lopez-Aguiar, Victoria R Rendell, et al.
The American Surgeon|November 11, 2021
Resection Status Does Not Impact Recurrence in Well-Differentiated Liposarcoma of the ExtremityChelsea R Olson, Lorena P Suarez-Kelly, Cecilia G Ethun, et al.
Annals of Surgical Oncology|August 7, 2016
Changing Odds of Survival Over Time among Patients Undergoing Surgical Resection of Gallbladder CarcinomaStefan Buettner, Georgios Antonios Margonis, Yuhree Kim, et al.
Annals of Surgical Oncology|November 11, 2015
Preoperative Helicobacter pylori Infection is Associated with Increased Survival After Resection of Gastric AdenocarcinomaLauren M Postlewait, Malcolm H Squires, David A Kooby, et al.
Journal of Surgical Oncology|December 6, 2017
Oncologic effects of preoperative biliary drainage in resectable hilar cholangiocarcinoma: Percutaneous biliary drainage has no adverse effects on survivalXu-Feng Zhang, Eliza W Beal, Katiuscha Merath, et al.
JAMA Surgery|October 27, 2016
Association of Optimal Time Interval to Re-resection for Incidental Gallbladder Cancer With Overall Survival: A Multi-Institution Analysis From the US Extrahepatic Biliary Malignancy ConsortiumCecilia G Ethun, Lauren M Postlewait, Nina Le, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 30, 2016
Elevated NLR in gallbladder cancer and cholangiocarcinoma - making bad cancers even worse: results from the US Extrahepatic Biliary Malignancy ConsortiumEliza W Beal, Lai Wei, Cecilia G Ethun, et al.
Pageof 63